Showing 2521-2530 of 2812 results for "".
- BTL Suit Alleges False Advertising by Allerganhttps://modernaesthetics.com/news/btl-suit-alleges-false-advertising-by-allergan-1/2472885/In a new lawsuit filed this week, BTL Industries alleges that Allergan launched a wide-ranging false and misleading advertising campaign relating to BTL's EMSCULPT device for non-invasive muscle toning and body shaping. The suit alleges that Allergan's marketing, sales materials, and soci
- Modern Aesthetics® Magazine’s Exclusive First Look at the Annual AAFPRS Survey Resultshttps://modernaesthetics.com/news/modern-aesthetics-magazines-exclusive-first-look-at-annual-aafprs-survey/2472881/Facial plastic surgery procedures increased 6 percent last year compared to 2018, according to the
- Allergan's New Philanthropic Program Will Benefit Kids with Upper Limb Spasticityhttps://modernaesthetics.com/news/allergans-new-philanthropic-program-will-benefit-kids-with-upper-limb-spasticity/2472879/Allergan is launching the Be The Difference philanthropic program to support children and their families who may benefit from treatment with Botox (onabotulinumtoxinA) for pediatric upper limb spasticity. Botox is approved to treat increased muscle stiffness in children 2 to 17 years of
- RealSelf Reveals List of Most Worth It Procedureshttps://modernaesthetics.com/news/realself-reveals-list-of-most-worth-it-procedures/2472877/A total of 15 nonsurgical and 37 surgical procedures earned Real Self’s Most Worth It designation for 2020. The RealSelf Worth It Rating is a proprietary consumer satisfaction score based on reviews from consumers on RealSelf who, after undergoing a treatment, rated it as "Wo
- Most Plastic Surgery YouTube and Social Media Videos Are Poor Qualityhttps://modernaesthetics.com/news/most-plastic-surgery-youtube-and-social-media-videos-are-poor-quality/2472874/YouTube and social media videos aren't necessarily the most reliable source of plastic surgery information, concludes a study in the February issue of Plastic and Reconstructive Surgery. Despite this, a recent American So
- From Baby Botox to Daddy Do-Overs, the Aesthetic Society Predicts the Hottest Trends for 2020https://modernaesthetics.com/news/from-baby-botox-to-daddy-do-overs-the-aesthetic-society-predicts-the-hottest-trends-for-2020/2472873/The Aesthetic Society predicts that 2020 will usher in the return of the facelift and the rise of the daddy do-over, i.e the male counterpart to t
- Alma’s Opus Plasma Debuts in North Americahttps://modernaesthetics.com/news/almas-opus-plasma-debuts-in-north-america/2472871/Alma, Inc. is launching Opus in North America. Opus is a new platform featuring the company's proprietary high-frequency unipolar radio-frequency technology, Opus Plasma. Opus Plasma is the first fractional plasma technology to enter the f
- New Data from Revian Red: System Shown to Support Hair Growthhttps://modernaesthetics.com/news/new-data-from-revian-red-system-shown-to-support-hair-growth/2472868/The Revian Red hair growth system demonstrates the ability to successfully stop hair loss and subsequently grow new hair, according to final data from a randomized, double-blind study. Findings were presented at the 2020 Winter Clinical Dermatology Conference – Hawaii an
- Revance Enters Exclusive Distribution Deal with Teoxane SA for Dermal Fillershttps://modernaesthetics.com/news/revance-enters-exclusive-distribution-deal-with-teoxane-sa-for-dermal-fillers/2472863/With the signing of a new distribution agreement, Revance Therapeutics, Inc. is now the exclusive US commercialization partner of Teoxane SA for its dermal filler products. Revance has immediate and exclusive rights to commercialize Teoxane’s Resilient Hyaluronic Acid® (R
- Revian: USPTO Grants Patent for Biostimulatory Approachhttps://modernaesthetics.com/news/regina-uspto-grants-patent-for-biostimulatory-approach/2472862/The United States Patent and Trademark Office (USPTO) has awarded to Revian Inc. U.S. Patent No. 10,265,258—the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body. The claims in this issued patent cover the use